PHIA Koninklijke Philips N.V.

Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere

Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere

November 24, 2025

  • New viewer offers full radiology capabilities, interfaces with AI and interactive reporting module to streamline workflows



Amsterdam, the Netherlands –
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Management 15, the next generation of Philips Vue PACS, including a zero-footprint, [1] that transforms how radiologists access and interpret medical images. Designed with a brand-new user interface, the viewer delivers the full clinical power of a desktop workstation through a standard web browser. It combines clinical depth, mobility, and scalability, enabling radiologists to work smarter, faster, and more collaboratively – while giving back time to clinical teams and reducing IT complexity across the enterprise.



A complete diagnostic experience – anytime, anywhere

In today’s healthcare environment, time, accuracy, and accessibility are critical. The viewer helps address one of healthcare’s most persistent challenges, lost clinical time caused by slow performance and the complexity of remote reading. It delivers high-performance server-side rendering, workflow automation, and a full suite of advanced clinical tools – all accessed securely through a web browser, with no local installation required.  

“We were among the first to test the new Philips web-based diagnostic viewer, and the difference is clear. It loads studies quickly and runs smoothly, even with large datasets. The new interface is intuitive and lets us focus entirely on the images, a real step forward in performance and usability,” said Pieter Hoste, Chief Radiologist and Head of Medical Imaging, AZ West Hospital, Belgium.

Processing between the client and server is optimized to ensure seamless performance, even with large, complex datasets such as digital breast tomosynthesis or cardiac CT. This delivers consistent, high-quality image interpretation – whether radiologists are working on-site, across the enterprise, or remotely – while simplifying IT deployment and management. 

The web-based viewer interfaces with connected AI tools to bring together all relevant patient information in one place, supporting faster, more informed diagnoses. Natively connected to the interactive reporting module, it manages reporting in the PACS workflow, eliminating the need for separate dictation or reporting systems and enabling radiologists to review images and generate comprehensive reports without leaving their reading application.

The new user interface provides access to a comprehensive suite of advanced clinical applications and accelerates interpretation by aligning images across modalities and time points, all seamlessly integrated with the interactive reporting application. Combined with the , which embeds deeper analysis results directly into the reporting workflow, clinicians benefit from greater efficiency and productivity. 

Cloud-enabled deployment for scalable, connected radiology

The viewer is built for cloud deployment through , powered by Amazon Web Services (AWS), with an on-premises option for added flexibility. This approach preserves current infrastructure investments and enables a seamless transition to the cloud at each organization’s pace.

“Health systems are under intense pressure to do more with less. The web diagnostic viewer is a milestone in our journey toward cloud-enabled, AI-integrated diagnostic imaging. It brings the power of advanced visualization, collaboration, and intelligence to any browser, helping radiologists stay connected and productive wherever care happens while streamlining IT operations,” said Madhuri Sebastian, Business Leader Imaging Informatics at Philips.

The web-based diagnostic viewer on Philips HealthSuite cloud is offered as a SaaS (Software as a Service) solution, with built-in security, and effortless scalability across multiple sites. It ensures consistent performance and collaboration for teams working on-site, remotely, or across borders and is currently available in the USA, with expansion to additional regions planned for 2026.

Philips at RSNA

At , Philips will highlight its new informatics solutions and AI-driven imaging ecosystem in development, featuring generative AI to automate workflow tasks like display protocol normalization and patient summaries, and Agentic AI [2] for anatomy-aware automation that streamlines study prioritization and workflow orchestration.

[1] The Philips web diagnostic viewer is available today to select customers, with broader market availability to follow. Future availability cannot be ensured.

[2] Work in progress, not available for global distribution. Future availability cannot be ensured.

For further information, please contact:

Anna Hogrebe

Philips Global External Relations

Tel.:

E-mail:

 

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.



Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachment



EN
24/11/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

Livio Luyten ... (+4)
  • Livio Luyten
  • Michiel Declercq
  • Thibault Leneeuw
  • Wim Hoste
Michiel Declercq
  • Michiel Declercq

Philips Ready to Start from a Clean Sheet

Running up to the CMD on 10 February, we initiate coverage on Philips with an Accumulate rating and a €27.5 TP. While we see potential for the company to positively surprise with its 2028 margin ambitions, investors will likely focus on the phasing, as 2026 margins will still be held back by tariff normalization. Nevertheless, with the majority of Respironics-related uncertainty now behind us, we believe Philips has room to increase shareholder returns and potentially announce a new share buybac...

 PRESS RELEASE

Philips named a Clarivate Top 100 Global Innovator for the 13th consec...

Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year January 21, 2026 Highest-ranking medical technology company recognized in the Clarivate Top 100 Global Innovators list for 2026Innovations for healthcare professionals and consumers that support better care delivery and improve people’s health and well-beingIndustry-leading commitment to R&D, with over EUR 1.7 billion invested annually, equivalent to approximately 9% of sales Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, has been named a for the 13th consecutive ...

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch